VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

The development of cancer is not a process triggered immediately by the emergence of an oncogenic mutation. There is growing ...

Researchers at Tel Aviv University's Gray Faculty of Medical and Health Sciences have uncovered how a natural and essential ...

Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

The same cellular renewal that keeps our bodies healthy might also fuel the growth of cancer. A UC Merced biologist has found that the brain could hold the key to stopping it. Professor Néstor Oviedo, ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...

Brain cancer breakthrough as new study finds cell therapy could target deadly glioblastoma - Patients diagnosed with ...

A recent study by a Florida-based university found promising results after examining the possibility of using sea squirts to ...